Certara, Inc. · NASDAQ:CERT
Certara — Technical Presentation (April 2015)
26 slides from Certara's technical presentation, Apr 8, 2015
Slide 1: Population Modeling of Modified Risk Tobacco Products
Population Modeling of Modified Risk Tobacco Products Bill Poland, PhD, Vice President and Lead Scientist, bill.poland@certara.com Jason Pirone, PhD, Scientist, jason.pirone@certara.com 8 April 2015
Slide 2: Agenda
Agenda The e-cigarette (and MRTP) dilemma How modeling can help; current models Data sources and modeling challenges Research directions and preliminary modeling insights © Copyright Certara, L.P. All rights reserved. 2
Slide 3: After the "cigarette century": what's the end game?
After the “cigarette century”: what’s the end game? 2014 http://www.surgeongeneral.gov/library/reports/50-years-of-progress/index.html#fullreport © Copyright Certara, L.P. All rights reserved. 3
Slide 4: Smoking still kills about 480,000 Americans per year
Smoking still kills about 480,000 Americans per year, reducing life spans 11-12 years. http://www.surgeongeneral.gov/library/reports/50-years-of-progress/index.html#fullreport © Copyright Certara, L.P. All rights reserved. 4
Slide 5: Nicotine hooks; tar kills.
Nicotine hooks; tar kills. Nicotine Tar Produced by the tobacco plant as a Contains hundreds of mutagens, natural pesticide carcinogens, and other toxins • Used as a pesticide in early 1900s • “Cigarette smoking has been Moderately to highly addictive causally linked to diseases of Suggestion but no
Slide 6: The FDA's Center for Tobacco Products defines and regulates MRTPs
The FDA’s Center for Tobacco Products (CTP) defines and regulates marketing of Modified Risk Tobacco Products (MRTPs). • An MRTP is “a product sold, distributed, or marketed with a claim to reduce harm or the risk of tobacco-related disease.” – E.g., with labels claiming lower risk than cigarettes.
Slide 7: E-cigarettes provide nicotine without toxic combustion products
E-cigarettes (e-cigs) provide nicotine—addictive but relatively safe— without toxic tobacco combustion products, raising hopes and fears. Sugerman DT. e-Cigarettes. JAMA 2014;311(2):212. http://jama.jamanetwork.com/article.aspx?articleid=1812964 © Copyright Certara, L.P. All rights reserved. 7
Slide 8: E-cig sales roughly doubling annually, could overtake cigarettes by 2023
E-cig sales have been roughly doubling annually since US introduction in 2007 and could even overtake cigarettes by 2023. Equivalent Pack Volume (in billions) 16.0 14.0 12.0 10.0 8.0 6.0 4.0 2.0 0.0 2011 2012 2013 2014E 2015E 2016E 2017E 2018E 2019E 2020E 2021E 2022E 2023E E-Cigarettes (in equivalen
Slide 9: E-cigarettes could make combusting of tobacco obsolete
One eminent researcher concluded “e-cigarettes, with prudent ... regulations, do have the potential to make the combusting of tobacco obsolete ... just as digital cameras made film obsolete.” Abrams DB. JAMA 2014;311(2): 135-136. http://jama.jamanetwork.com/article.aspx?articleid=1812971 © Copyright
Slide 10: Worst-case scenario emphasis: time for probabilistic modeling
Another researcher emphasizes a worst-case scenario. Time for probabilistic modeling! Best Case Worst Case Massive migration of smokers into Massive migration of smokers and e-cig vaping non-smokers into e-cig vaping • Like digital cameras • Like cell phone adoption replacing film • Non-users drawn
Slide 11: Population models used for decades to predict smoking prevalence
Population models have been used for decades to predict smoking prevalence and mortality. Mendez D 2011. Modeling the Population Dynamics of Smoking Prevalence and Health Effects, Washington DC, 9 May2011. http://www.iom.edu/~/media/Files/Activity%20Files/PublicHealth /ReducedRiskTobacco/MendezPrese
Slide 12: Basic population model: equilibrium may take over a century
With a basic population model, we found that even with fixed not time-varying parameters, reaching equilibrium smoking prevalence may take over a century (and mortality even longer). 100% 0% 90% 10% 80% 20% Never-Smoker Proportion 70% 30% Smoker Proportion 60% 40% 50% 50% Never-Smokers 40% 60% 30% 7
Slide 13: Most smoking prediction models: Markov chain or Monte Carlo
Most smoking prediction models have taken one of these approaches: • Markov chain (dynamic systems) – Divide population into groups by use status (never, current, former by years since quitting), age, sex, possibly cigarettes/day (cpd) category – From initial levels and transition (including death)
Slide 14: New generation of population models predicting two-product effects
A new generation of population models is starting to predict effects of two tobacco products including dual use. PLOS One, 27 March 2015 http://journals.plos.org/plosone/ar ticle?id=10.1371/journal.pone.01 21008 Regulatory Toxicology and Pharmacology, available online 27 March 2015 http://www.scienc
Slide 15: The Sandia/FDA model of cigarette and e-cig use states
The Sandia/FDA model considers every combination of never, current, and former user of product #1 (cigarettes) and #2 (e-cigs). Verzi S 2014. http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMateri als/TobaccoProductsScientificAdvisory Committee/UCM394231.pdf “gateway to smoking” re
Slide 16: Simplifications leave about a dozen uncertain transition rates
We make some simplifications, but about a dozen highly uncertain transition rates remain. Assume • one product change at a time • no relapse, except by former x smokers via e-cigs x x x x “gateway to smoking” x x x x relapse to cigs. x via e-cigs x x x “gateway from smoking” E.g., cig. / e-cig 16 ©
Slide 17: Quasi Monte Carlo simulation of individual tobacco use histories
For flexibility, we use “quasi” Monte Carlo simulation of individual tobacco use histories across a large population. Advantage of individual simulation: no practical limits on the number of distinct groups (states) • E.g., mortality can easily be made a function of cpd category or full tobacco use
Slide 18: Probabilistic analysis translates input uncertainty into output uncertainty
Probabilistic analysis translates input uncertainty into output uncertainty. Wide input distributions result in wide distributions on possible net health impacts of e-cigs, from negative to positive. • Wide distributions are more “honest” than point estimates Smoking Prevalence in 2060 7.0% 9.0% 11.
Slide 19: Relative risk of the MRTP is a key uncertainty
Relative risk of the MRTP is a key uncertainty. A simpler type of breakeven analysis can be useful. Vugrin E et al. 2015. PLoS ONE 10(3): e0121008. doi: 10.1371/journal.pone.01 21008 http://journals.plos.org/pl osone/article?id=10.1371 /journal.pone.0121008 Breakeven in 2050 © Copyright Certara, L.P
Slide 20: Data sources include:
Data sources include: • For cigarette smoking initiation, prevalence, use levels, and cessation rates: US national surveys, with age and gender breakdown – National Survey on Drug Use and Health (NSDUH) – National Health Interview Survey (NHIS) – Tobacco Use Supplement to the Current Population Surv
Slide 21: Former smoker mortality risk vs. years since quitting
Former smoker mortality risk has been modeled vs. years since quitting. Quitting by 40 may return risk to non-smoker levels. Data: Cancer Prevention Study II (CPS-II) Mendez D, Warner KE 2001. “The relative risk of death for former smokers: the influence of age and years-quit.” Unpublished research
Slide 22: Dual users: what is the mortality benefit of fewer cigarettes per day?
Dual users smoke may smoke < ½ as many cigarettes/day (cpd): what’s the mortality benefit? Most models assume none, but look at the data. 5 Thun MJ et al. 2013. 50-year trends in smoking-related mortality in the United States. N Engl J Med Jan 24;368(4):351-64. 40+ http://www.nejm.org/doi/pdf/10.105
Slide 23: Relating mortality to cigarettes per day with Tobacco Exposure Index
One of the few attempts to relate mortality to cpd used a Tobacco Exposure Index to account for lifetime smoke toxin accumulation. 2 packs/day never-smoker Miller LS et al. 2010. Evaluation of the economic impact of California’s Tobacco Control Program: a dynamic model approach. Tobacco Control 19(S
Slide 24: Key research steps needed to evaluate net MRTP effects
Key research steps needed to evaluate net MRTP effects include: Improve estimates and ranges of MRTP transition rates • Initiation, full and partial switching from cigarettes, relapse back to cigarettes, “gateway” to cigarettes, quit rates • Snus analogy is useful as a scenario • Elicit subjective r
Slide 25: Insights from preliminary population modeling with MRTPs
Some insights from preliminary population modeling with MRTPs: Net prevalence and mortality effects of MRTPs are sensitive to highly uncertain inputs. • Future research will narrow uncertainties somewhat, but we must accept broad- ranging possibilities including both negative and positive net impact
Slide 26: Thank you! Questions?
Thank you! Questions? Abrams 2014. e-Cigarettes: Can we use them to make combusting of tobacco obsolete - end the “cigarette century” and its preventable deaths? Presentation to American Academy of Health Behavior 14th Annual Meeting. http://www.aahb.org/Resources/Pictures/Meetings/2014-Charleston/P